Showing 2521-2530 of 2891 results for "".
- Hydrafacial and Glytone Team Up to Launch New Boosterhttps://modernaesthetics.com/news/hydrafacial-and-glytone-team-up-to-launch-new-booster-1/2473323/The Beauty Health Company’s Hydrafacial is rolling out a new exfoliating booster co-created with Glytone. The Glytone AHA Resurfacing Cellular Booster leverages a unique combination of three alpha hydroxy acids (AHAs) that may help improve the appearance of skin surface and textur
- Teyana Taylor Tapped as New Xeomin Brand Partnerhttps://modernaesthetics.com/news/teyana-taylor-tapped-as-new-xeomin-brand-partner/2473321/Xeomin, an FDA-approved double filtered anti-wrinkle injection to temporarily improve the appearance of frown lines with only the ingredients that work and none that don’t. “I always strive to understand the ingredients in any product I’m using and listen to trusted so
- Evio Beauty Supports Domestic Violence Survivorshttps://modernaesthetics.com/news/evio-beauty-supports-domestic-violence-survivors/2473319/Evio Beauty is teaming up with FreeFrom, a US-based non-profit organization dedicated to helping survivors of intimate partner violence achieve economic justice and long-term financial stability. Evio will donate one dollar from every sale of their Lip Serum (in any shade) to FreeFrom.
- U.S. FDA Clears EndyMed’s Pure Laser Hair Removal Devicehttps://modernaesthetics.com/news/us-fda-clears-endymeds-pure-laser-hair-removal-device/2473318/The US Food and Drug Administration has cleared Endymed Ltd’s Pure Laser hair removal device for the marketing and sales. The Pure Laser was developed in the Company's labs by its subsidiary Endymed Medical Ltd. The Company intends to commence marketing in the US th
- Hugel Resubmits BLA for Botulaxhttps://modernaesthetics.com/news/hugel-resubmits-bla-for-botulax/2473314/Hugel resubmitted the BLA for its botulinum toxin called Botulax for smoothing glabellar lines to the U.S. FDA. Hugel had received a Complete Response Letter (CRL) from the U.S. FDA last March after submitting the BLA for Botulax (50 and 100 units) to advance into the U.S. market i
- Curtis Cluff Named President and CFO of BioPhotas Inc.https://modernaesthetics.com/news/curtis-cluff-named-president-and-cfo-of-biophotas-inc/2473313/Curtis Cluff is the new President and Chief Financial Officer BioPhotas Inc., manufacturers of the Celluma series of light therapy devices. In this newly created role, Mr. Cluff will report to Patrick Johnson, Chief Executive Officer and inventor of the Celluma. &quo
- New Indications for SkinPen in the EU and UKhttps://modernaesthetics.com/news/new-indications-for-skinpen-in-the-eu-and-uk/2473310/Crown Aesthetics’ SkinPen Precision scored three new approved indications in the EU and UK. The new&
- New Research Highlights the Efficacy and Safety Profile of Revance's DAXXIFYhttps://modernaesthetics.com/news/new-research-highlights-the-efficacy-and-safety-profile-of-revances-daxxify/2473304/Two new studies highlight the efficacy and safety profile of Revance Therapeutics, Inc.’s newly approved DAXXIFY (DaxibotulinumtoxinA-lanm). Glabellar injection of DAXXIFY showed a positive effect on eyebrow position, with a modest reduction in forehead muscle activity in&nbs
- BuildMyHealth Names First Chief Revenue Officerhttps://modernaesthetics.com/news/buildmyhealth-points-first-chief-revenue-officer/2473302/BuildMyHealth, developer of the No Surprises Act price transparency and lead conversion platform, has its first Chief Revenue Officer. Chad Sawyer was previously a national sales executive with both Crystal Clear Digital Marketing and Patient Now. In those roles, Mr. Sawyer helped hundreds of pra
- BTL Introduces EMFACEhttps://modernaesthetics.com/news/btl-introduces-emface/2473301/BTL is taking on the minimally invasive facial aesthetic category with the launch of EMFACE. Emface simultaneously emits both